Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Gastrointestinal Neoplasms 1Cancer Pain 1Adult Patients Who Are Receiving Oncologic Care 1Adjustment Disorders 1

Interventions

Fluorouracil 7Oxaliplatin 6Leucovorin 5Capecitabine 4Blood Specimen Collection 4Bevacizumab 4Pafolacianine 3Irinotecan 3Cisplatin 3Cetuximab 3pembrolizumab 2atezolizumab 2XELOX 2Surveys and Questionnaires 2Standard of Care 2Specimen Handling 2Paclitaxel 2IDRX-42 2Gemcitabine 2Folfox protocol 2Endoscopic Mucosal Resection 2Drug Therapy 2Docetaxel 2Carboplatin 2130-nm albumin-bound paclitaxel 2trastuzumab deruxtecan 1sodium thiosulfate 1sodium propionate 1sacituzumab govitecan 1s-formylglutathione hydrolase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Gastrointestinal Neoplasms × Pharmacogenomic Testing × Clear all
NCT06489041 2026-02-02

Evaluating Microarray Pharmacogenetic Testing in Cancer Patients

Wake Forest University Health Sciences

Phase NA Recruiting
120 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡